PrP Sc -selective peptides

Details PrP Sc -selective peptides PrP Sc -selective peptides

2006-01-27

2008-10-14

Campell, Bruce (Department: 1648)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

C424S130100, C424S139100

Reexamination Certificate

active

07435540

ABSTRACT:
The present invention features methods for identifying peptides that selectively bind to PrPScor fragments thereof. The invention also features the use of such peptides in screening methods for the identification of candidate agents useful for the treatment of a prion disease.

REFERENCES:
patent: 4806627 (1989-02-01), Wisniewski et al.
patent: 5597725 (1997-01-01), Suzuki
patent: 5639634 (1997-06-01), Suzuki
patent: 5643781 (1997-07-01), Suzuki
patent: 5646250 (1997-07-01), Suzuki
patent: 5663300 (1997-09-01), Suzuki
patent: 5679530 (1997-10-01), Brentani et al.
patent: 5708143 (1998-01-01), Suzuki
patent: 5750361 (1998-05-01), Prusiner et al.
patent: 5773572 (1998-06-01), Fishleigh et al.
patent: 5798224 (1998-08-01), Suzuki
patent: 5846533 (1998-12-01), Prusiner et al.
patent: 5891641 (1999-04-01), Prusiner et al.
patent: 5891706 (1999-04-01), Suzuki
patent: 6355610 (2002-03-01), Chesebro et al.
patent: 6451541 (2002-09-01), Winnacker et al.
patent: 6462171 (2002-10-01), Soto-Jara et al.
patent: 2004/0072236 (2004-04-01), Cashman et al.
patent: 197 41 607 (1999-03-01), None
patent: 0 861 900 (1998-09-01), None
patent: 1529119 (1989-12-01), None
patent: WO 87/06706 (1987-11-01), None
patent: WO 92/06220 (1992-04-01), None
patent: WO 92/08731 (1992-05-01), None
patent: WO 93/11155 (1993-06-01), None
patent: WO 93/23432 (1993-11-01), None
patent: WO 94/01116 (1994-01-01), None
patent: WO 96/32128 (1996-10-01), None
patent: WO 96/39834 (1996-12-01), None
patent: WO 97/10505 (1997-03-01), None
patent: WO 97/16728 (1997-05-01), None
patent: WO 97/43649 (1997-11-01), None
patent: WO 97/45746 (1997-12-01), None
patent: WO 98/37210 (1998-08-01), None
patent: WO 99/15651 (1999-04-01), None
patent: WO 99/19360 (1999-04-01), None
patent: WO 99/42829 (1999-08-01), None
patent: WO 00/78344 (2000-12-01), None
patent: WO 00/78344 (2000-12-01), None
patent: WO 01/00235 (2001-01-01), None
Korth et al., “Acridinie and phenothiazine derivatives as pharmacotherapeutics for prion disease”, Proc. Natl. Acad. Sci USA 98:9836-9841 (2001).
Ma et al., “Molecular dynamics simulations of alanine rich beta-sheet oligomers: Inshight into amyloid formation” Prot. Sci. 11:2335-2350 (2002).
Zou, et al., “All or none fibrillogenesis of a prion peptide”, Eur. J. Biochem. 268:4885-4891 (2001).
International search report No. PCT/US03/30273 mailed Oct. 19, 2005.
West et al., “De novo amyloid proteins from designated combinatorial libraries”, Proceedings of the National Academy of Science (1999) vol. 96, pp. 11211-11216.
Medline Accession #AAA67439 dated May 25, 1995.
Bradley, “BSE Transmission Studies with Particular Reference to Blood”, Dev. Biol. Stand. 99:35-40 (1999).
Cai, et al., “Solvent-Dependent Precipitation of Prion Protein”, Biochimica et Biophysica Acta 1597:28-35 (2002).
Cashman et al., “A Prion-Specific Immunological Epitope,” Abstracts of the Society for Neuroscience 27:1743 (2001).
Caughey, “Probing for Prions: Recognizing Misfolded PrP”, Nature Medicine 9:819-820 (2003).
Come et al., “A Kinetic Model for Amyloid Formation in the Prion Diseases: Importance of Seeding”, Proc. Natl. Acad. Sci. USA 90:5959-5963 (1993).
Demart et al., “New Insight into Abnormal Prion Protein Using Monoclonal Antibodies”, Biochem. Biophys. Res. Commun. 165:652-657 (1999).
Gorochov et al., “Properties of a Disease Specific Prion Probe”, Nature Medicine 10:11 (2004).
Krasemann et al., “Generation of Monoclonal Antibodies Against Human Prion Proteins in PrP0/0 mice”, Mol. Med. 2:725-734 (1996).
Krasemann et al., “Induction of Antibodies Against Human Prion Proteins (PrP) by DNA-mediated Immunization of PrP0/0 Mice”, J. Immunol. Methods 199:109-118 (1996).
Krasemann et al., “Generation of Monoclonal Antibodies Against Prion Proteins with an Unconventional Nucleic Acid-based Immunization Strategy”, J. Biotechnol. 73:119-129 (1999).
Meggio, et al., “Bovine Prion Protein as a Modulator of Protein Kinase CK2”, Biochem. J. 352:191-196 (2000).
Morel et al., “Selective and Efficient Immunoprecipitation of the Disease-Associated Form of the Prion Protein can be Mediated by Nonspecific Interactions Between Monoclonal Antibodies and Scrapie-Associated Fibrils”, J. Biol. Chem. 279:30143-30149 (2004).
Paramithiotis et al., “Properties of a Disease Specific Prion Probe, Reply”, Nature Medicine 10:11-12 (2004).
Paramithiotis et al., “A Prion Protein Epitope Selective for the Pathologically Misfolded Conformation”, Nature Medicine 9:893-899 (2003).
Serbec et al., “Monoclonal Antibody against a Peptide of Human Prion Protein Discriminates between Creutzfeldt-Jacob's Disease-Affected and Normal Brain Tissue”, J. Biol. Chem. 279:3694-3698 (2004).
Vorberg, et al., “A Novel Eptiope for the specific Detection of Exogenous Prion Proteins in Transgenic Mice and Transfected Murine Cell Lines”, Virology, 255:26-31 (1999).
Zou et al., “Acidic pH and Detergents Enhanced In Vitro Conversion of Human Brain PrPcto to a PrPsc- like form”, J. Biol. Chem. 277:43942-43947 (2002).
Zou et al., “Antibody to DNA Detects Scrapie but not Normal Prion Protein”, Proc. Natl., Acad. Sci USA 3:1380-1385 (2004).
Arrou et al., “Enantioselective Separation of Basic Amino Acids on Talc”, J. Chem. Tech. Biotechnol. 63:92-96 (1995).
Chadha, et al., “Heparin Binding Sites on Prions”, Int. J. of Bio-Chromotography 2:211-223 (1997).
Lindon et al., “Separation and Characterization of Components of Peptide Libraries”, Magn. Reson. Chem. 33:857-863 (1995).
Steiner, T., “Structural Evidence for the Aromatic -(/+1) Amine Hydrogen Bond in Peptides: L-Tyr-L-Tyr-L-Leu Monohydrate”, Acta. Cryst. D54, 584-588 (1998).
Bacon and Anderson, “Multiple Sequence Alignment”, J. Mol. Biol., 191:153-161 (1986).
Bendheim et al., “Antibodies to a Scrapie Prion Protein”, Nature 310:418-421 (1984).
Bennet et al., “3D Domain swapping: A mechanism for oligomer assembly”, Protein Science 4:2455-2468 (1995).
Bolton et al., “Identification of a Protein that Purifies with the Scrapie Prion”, Science 218:1309-1311 (1982).
Bolton and Bendheim, “A modified host protein model of scrapie”, Ciba Found. Symp. 135:164-177 (1988).
Brown et al., “Iatrogenic Creutzfeldt-Jakob disease at the millennium”, Neurology 55:1075-1081 (2000).
Bueler et al., “Mice Devoid of PrP Are Resistant to Scrapie”, Cell 73:1339-1347 (1993).
Bueler et al., “Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein”, Nature 356:577-582 (1992).
Cashman, “A prion primer”, Canadian Medical Association Journal 157:1381-1385 (1997).
Cashman et al., “Cellular Isoform of the Scrapie Agent Protein Participates in Lymphocyte Activation”, Cell 61:185-192 (1990).
Caughey et al., “Binding of the Protease-Sensitive Form of Prion Protein PrP to Sulfated Glycosaminoglycan and Congo Red”, Journal of Virology 68:2135-2141 (1994).
Chandler, “Encephalopathy in Mice Produced by Inoculation with Scrapie Brain Material”, Lancet 6:1378-1379 (1961).
Chemical Abstract 122:49358 CA (XP-002056077) (1992).
Cheng etal., “Identification and Cloning of ELF-1, a Developmentally Expressed Ligand for the Mek4 and Sek Receptor Tyrosine Kinases”, Cell 79:157-168 (1994).
Collinge, “Variant Creutzfeldt-Jakob disease”, Lancet 354:317-323 (1999).
Collinge, et al., “Prion protein is necessary for normal synaptic function”, Nature 370:295-297 (1994).
Coulthart and Cashman, “Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health”, Canadian Medical Association Journal 165:51-58 (2001).
Dayhoff, et al., “A Model of Evo

Affiliated with

Also associated with

Rating

PrP Sc -selective peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PrP Sc -selective peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PrP Sc -selective peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3988482